Holen Sie sich die Stockscreener-App
19.23
0.00%
0.00
Vorhandelsmarkt:
19.50
0.27
+1.40%
Schlusskurs vom Vortag:
$19.23
Offen:
$19.1
24-Stunden-Volumen:
367.78K
Relative Volume:
0.79
Marktkapitalisierung:
$872.47M
Einnahmen:
$719.89M
Nettoeinkommen (Verlust:
$98.09M
KGV:
9.4571
EPS:
2.0334
Netto-Cashflow:
$118.98M
1W Leistung:
-1.44%
1M Leistung:
-30.50%
6M Leistung:
-28.43%
1J Leistung:
-32.43%
1-Tages-Spanne:
$18.98
$19.57
1-Wochen-Bereich:
$18.97
$20.08
52-Wochen-Spanne:
$17.03
$31.26
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Firmenname
Amphastar Pharmaceuticals Inc
Sektor
Telefon
909-980-9484
Adresse
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
19.23 | 872.47M | 719.89M | 98.09M | 118.98M | 2.0334 |
TAK
Takeda Pharmaceutical Co Adr
|
18.04 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
115.93 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.70 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.14 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
531.82 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2025-08-12 | Hochstufung | Needham | Hold → Buy |
| 2025-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-03-05 | Eingeleitet | JP Morgan | Overweight |
| 2023-11-17 | Eingeleitet | BofA Securities | Neutral |
| 2023-07-25 | Fortgesetzt | Jefferies | Buy |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2022-07-29 | Eingeleitet | CapitalOne | Overweight |
| 2022-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Eingeleitet | Northland Capital | Outperform |
| 2019-03-13 | Herabstufung | Needham | Buy → Hold |
| 2019-03-13 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Bestätigt | Needham | Buy |
| 2018-03-13 | Bestätigt | Needham | Buy |
| 2017-12-01 | Bestätigt | Needham | Buy |
| 2017-11-09 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Bestätigt | Needham | Buy |
| 2017-03-14 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Bestätigt | Needham | Buy |
| 2016-05-10 | Bestätigt | Needham | Buy |
| 2016-02-19 | Eingeleitet | Wells Fargo | Outperform |
| 2015-06-19 | Bestätigt | Needham | Buy |
| 2015-06-03 | Eingeleitet | Raymond James | Strong Buy |
| 2014-07-21 | Eingeleitet | Needham | Buy |
Alle ansehen
Amphastar Pharmaceuticals Inc Aktie (AMPH) Neueste Nachrichten
Portfolio Update: Is Amphastar Pharmaceuticals Inc backed by strong institutional buyingPortfolio Risk Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Institution Moves: Is Amphastar Pharmaceuticals Inc forming a double bottom2026 Biggest Moves & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Aug Outlook: Can Amphastar Pharmaceuticals Inc stock outperform in a bear marketWeekly Investment Recap & AI Driven Price Forecasts - baoquankhu1.vn
Stock Market Recap: Is Amphastar Pharmaceuticals Inc a potential multi bagger2026 Volatility Report & Fast Gaining Stock Reports - baoquankhu1.vn
Amphastar (AMPH) EVP Yakob has 1,033 shares withheld for RSU tax - Stock Titan
[Form 4] Amphastar Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Tax withholding trims Amphastar (NASDAQ: AMPH) exec's RSU shares - Stock Titan
Tax withholding on RSU vesting for Amphastar (AMPH) CFO Peters - Stock Titan
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - Yahoo Finance
NeoGenomics, Natera, and Amphastar Pharmaceuticals shares skyrocket, what you need to know - MSN
Amphastar Pharmaceuticals Inc authorizes $50 million increase to share buyback program on March 12, 2026SEC filing - marketscreener.com
Amphastar Pharmaceuticals IncAuthorizes $50 Million Increase To Share Buyback Program On March 12, 2026SEC Filing - TradingView
Amphastar Expands Share Repurchase Authorization to Manage Equity - TipRanks
Amphastar Pharmaceuticals boosts buyback program by $50 million - TradingView
Amphastar (NASDAQ: AMPH) adds $50 million to share buyback program - Stock Titan
Clark Capital Management Group Inc. Invests $7.56 Million in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Algert Global LLC Acquires 268,612 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals: Why I Like Bull Put Options Strategy Here (NASDAQ:AMPH) - Seeking Alpha
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Rating of "Hold" from Analysts - MarketBeat
Amphastar reports FDA approval for teriparatide injection - MSN
Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Barclays 28th Annual Global Healthcare ConferenceSlideshow - Seeking Alpha
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 12-Month LowShould You Sell? - MarketBeat
Amphastar (AMPH) CFO granted RSUs, stock options and withholds shares for taxes - Stock Titan
Risk Report: Can Amphastar Pharmaceuticals Inc maintain its current growth rateRate Hike & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Amphastar (AMPH) exec granted RSUs, options and reports tax share withholding - Stock Titan
Amphastar (NASDAQ: AMPH) EVP receives RSUs and stock option grant - Stock Titan
Equity awards and tax withholding for Amphastar Pharmaceuticals (AMPH) insiders - Stock Titan
Amphastar (AMPH) CFO Peters reports 2,146-share tax-withholding on RSU vesting - Stock Titan
Amphastar (AMPH) CEO logs 10,850-share RSU tax withholding, retains large stake - Stock Titan
Amphastar Pharmaceuticals : Barclays 28th Annual Global Healthcare Conference Presentation - marketscreener.com
Amphastar (AMPH) senior EVP uses 1,357 shares to cover RSU taxes, retains over 240K - Stock Titan
AMPH SEC FilingsAmphastar Pharma 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Shorts: Can Amphastar Pharmaceuticals Inc maintain its current growth rateJuly 2025 Price Swings & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Can Amphastar Pharmaceuticals Inc. stock reach $100 price targetIPO Watch & Daily Profit Maximizing Trade Tips - Naître et grandir
Risk Check: Is Amphastar Pharmaceuticals Inc a potential multi baggerGold Moves & High Accuracy Swing Trade Signals - baoquankhu1.vn
Vanguard Group Inc. Has $70.12 Million Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Generic Pharmaceuticals Q4 2025 Review: Revenue Beat, Stock DeclineNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Amphastar Pharmaceuticals signs new executive employment agreements - Investing.com UK
Amphastar Pharmaceuticals signs new executive employment agreements By Investing.com - Investing.com UK
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance
Amphastar Updates Executive Employment Agreements to Strengthen Leadership - TipRanks
Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3SEC Filing - TradingView
Family-linked China partners sign new Amphastar (NASDAQ: AMPH) deals - Stock Titan
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year LowShould You Sell? - MarketBeat
According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), Amphastar Pharmaceuticals Inc has signed a five-year supply agreement, under which all payments will be settled in RMB. - Bitget
Amphastar Pharmaceuticals Balances Growth Plans With Margin Risks - TipRanks
Generic Pharmaceuticals Stocks Q4 Highlights: Amphastar Pharmaceuticals (NASDAQ:AMPH) - Finviz
Amphastar Pharmaceuticals Hits Day Low of $19.83 Amid Price Pressure - Markets Mojo
Amphastar Pharmaceuticals Stock Plummets to New 52-Week Low of $19.83 - Markets Mojo
Royce & Associates LP Raises Stock Holdings in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals to Present at the Barclays 28th Annual Global Healthcare Conference - ACCESS Newswire
Finanzdaten der Amphastar Pharmaceuticals Inc-Aktie (AMPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Amphastar Pharmaceuticals Inc-Aktie (AMPH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Zhou Rong | SENIOR EVP, PRODUCTION CENTER |
Dec 17 '25 |
Sale |
26.20 |
9,787 |
256,379 |
138,043 |
| Petersen Floyd F. | Director |
Dec 12 '25 |
Sale |
25.92 |
2,426 |
62,888 |
71,368 |
| Petersen Floyd F. | Director |
Dec 11 '25 |
Sale |
25.69 |
1,737 |
44,620 |
73,794 |
1.75%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):